Nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) was investigated in male Wistar rats. When CDDP in a single dose of 4 mg kg was injected i.p, into animals, serum creatinine (Cr) and blood urea nitrogen (BUN) reached a peak after 4 days and returned to the initial levels within two weeks. Nephrotoxicity of CDDP was dose-dependent, and related to the route of administration in the following order of i.p.s.c.i.v. When CDDP (4 mg kg) was injected i.p. repeatedly at intervals of three weeks, a decrease in nephrotoxicity was observed after the 2nd injection of drug. This decreased nephrotoxicity was detected as early as a week after the 1st injection. Following the 3rd injection, nephrotoxicity showed an accumulative pattern. The change in the route of administration or its regimen did not alter the pattern of CDDP-induced nephrotoxicity. Decreased nephrotoxicity after the 2nd injection of the drug seems to be interesting from viewpoint of a host defense response.
cis-diamminedichloroplatinum ; nephrotoxicity Hosokawa et al. 1984 ). However, the causes and ways of prevention of CDDPinduced nephrotoxicity have not been well established yet. During the investigation of the nephrotoxicity following administration of CDDP in rats, we found that the peak levels of Cr and BUN were rather lower after the 2nd administration than after the 1st one. In this paper, the pattern of nephrotoxicity following a single and repeated administration of CDDP is reported with special attention to the levels of nephrotoxicity induced by the 2nd administration.
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MATERIALS AND METHODS
Animal. Male Wistar rats were obtained from the Shizuoka Agricultural Cooperative Association for Laboratory Animals, Hamamatsu. Rats weighing 280-350 g,10-12 weeks of age, were used.
Biochemical examination. At each sampling, about 1 ml of blood was collected from the tail vein, and the blood was assayed for blood urea nitrogen (BUN), serum creatinine (Cr), calcium (Ca), inorganic phosphorus (P) and sodium (Na). Serum Na was measured by flamephotometry, Ca by orthocresol phthalein complexone method, P by molybdic acid direct method, Cr by alkaline picrate method and BUN by urease UV method.
Anticancer drug. cis-Diamminedichloroplatinum (CDDP) was supplied by Nippon Kayaku Co., Ltd., Tokyo.
Statistical analysis. The significance of differences was calculated using Student's t-test.
RESULTS
Nephrotoxicity following a single administration of CDDP When a single dose of 4 mg/kg of CDDP was injected i.p, into male Wistar rats, serum Cr and BUN reached a peak after 4 days, and returned to the initial levels within 14 days (Table 1) . A slight decrease of serum P and Na occurred a little later than the peak of Cr and BUN. Serum Ca remained unchanged. Body weight decreased to around 90% of initial weight at day 4, and recovered gradually (data not shown). The distribution of Cr level at the peak of day 4 was shown in Table 2 .
Effects of the dose and the administration route of CDDP on the nephrotoxicity were then examined. The levels of both Cr and BUN at the peak of day 4 were dependent on the dose of CDDP (Table 3) . When 2 mg/kg of CDDP was injected, no changes in serum Cr and BUN were observed. On the other hand, when 8 mg/kg was used, all animals died 8-11 days later. Therefore, 4 mg/kg of CDDP was employed in the following experiments. With regard to the administration route, the i.p, route was the most nephrotoxic (Table 4) . Nephrotoxicity following repeated administration of CDDP Animals whose Cr levels had been over 0.8 mg/100 ml at day 4 after the 1st administration of CDDP were used in the following experiments. CDDP (4 mg/ kg) was repeatedly injected i.p. four times at intervals of three weeks, and a pattern of CDDP-induced nephrotoxicity was examined. As shown in Fig. 1 , the peak levels of serum Cr and BUN after the 2nd injection of CDDP were significantly lower than those measured after the 1st injection. After the 3rd and 4th injections, levels of Cr and BUN increased in an accumulative manner.
Then the 2nd injection was given at different time intervals. As shown in Table 5 , the lower level of Cr at day 4 was observed as early as a week after the 1st injection. When the interval between the two injections was lengthened up to 8 weeks, the difference in Cr level at day 4 between the 1st and 2nd injection became smaller.
In order to obtain more information about this unexpected phenomenon, the effects of administration regimen and route on the pattern of nephrotoxicity following the 2nd administration of CDDP were examined (Table 6) . CDDP was injected i.p. at a dose of 2 mg/kg/day for two consecutive days. Nephrotoxicity following two daily consecutive administration of 2 mg/kg was less potent than that induced by a single administration of 4 mg/kg at the 1st injection. However, the drop in the levels of serum Cr after the 2nd administration was persistent in both regimens. The i.v. injection showed a basically similar pattern to that of the i.p. injection.
DISCUSSION
In the present studies with rats, we examined the effects of administration route, regimen, and frequency of CDDP on the nephrotoxicity. Nephrotoxicity TABLE 6 . Effects on serum Cr levels of administration regimen and route of the 2nd i . p . administration o f CDDP of MMC is well known (Valavaara and Nordman 1985) . In our experiment, CDDP (4 mg/kg) was more nephrotoxic than MMC (1.5 mg/kg), ADR (8 mg/kg) or CY (65 mg/kg) (data not shown). Nephrotoxicity was dose-related, and a single administration of 4 mg/kg was more nephrotoxic than were two daily consecutive administrations of 2 mg/kg. Lagasse et al. (1981) reported that the changes in serum Cr and BUN were similar between i.p. and i.v. routes in dogs. But in our experiment with rats, CDDP by the i.p. route was more nephrotoxic than by the iv. route. The pattern of the changes in serum Cr and BUN following repeated i.p. administration of CDDP was unexpected. As far as we know, no reports have been published concerning the phenomenon which we have shown here. The decrease in the levels of Cr and BUN after the 2nd injection of CDDP was persistently observed in all the intervals tested, and regardless of the administration route and regimen. We measured the values of Cr and BUN at days 3 and 4 after the 2nd administration in order to check the possibility that the day of the peak of Cr and BUN values might appear earlier than the 4th day at the 2nd one. The levels of Cr and BUN at day 3 were as low as those at day 4. So this possibility was denied. In morphologic studies, there was a good correlation between Cr values and renal injury (data not shown). Decreased nephrotoxicity after the 2nd injection agreed with the histopathological findings. Namely, light microscopic features 4 days after the 1st administration of CDDP (4 mg/kg, i.p.) were characterized by hydropic degenerative necrosis of the renal tubular epithelium. However, degenerative changes 4 days after the 2nd injection were very slight, and regeneration of tubules was noted. Following the 3rd or 4th injection, mild to severe interstitial fibrosis developed.
The mechanisms for the decreased nephrotoxicity after the 2nd administration of CDDP are entirely obscure at the present time. We are speculating that this phenomenon might be related to a certain kind of host defense response. Some enzymes in renal epithelium which could reduce the renal toxicity of CDDP might be reboundly activated after the 1st administration of CDDP. Further experiments are required to clarify the precise mechanisms. Knowing the adverse effects of chemotherapeutic agents and knowing how to reduce their adverse effects are, we believe, very important for successful cancer chemotherapy.
